During the follow-up period, none of the patients died, and 3.5% were referred for conventional angiography for recurrent or worsening chest pain.

随访期间，没有病人死亡，3.5%的患者因再出现或加重胸痛而接受传统造影术。

youdao

Makhija said the new combination added weeks to the standard survival period for recurrent patients, and the drug combo was well-tolerated by the body and caused minimal side effects.

Makhija说到这种新的联合疗法可增加复发患者生存期的周数，而药物也较易为病人耐受且仅引起轻微不良反应。

youdao

Follow-up period did not find recurrent.

随访期间未发现复发病例。

youdao